Literature DB >> 9169850

Flk-1 expression defines a population of early embryonic hematopoietic precursors.

N Kabrun1, H J Bühring, K Choi, A Ullrich, W Risau, G Keller.   

Abstract

We have investigated the expression pattern of the Flk-1 receptor tyrosine kinase in mouse embryonic and fetal hematopoietic tissues as well as on hematopoietic precursor cells derived from these tissues. RNA analysis indicated that flk-1 was expressed in the yolk sac at day 10 of gestation, in the whole embryo at day 10 and 12 of gestation, in the liver throughout fetal life and in embryoid bodies (EBs) generated from ES cells differentiated in culture. Flk-1 message was also detected in erythroid and macrophage colonies generated from precursors of yolk sac, fetal liver, adult marrow and EB origin. Using an antibody directed against the extracellular portion of the molecule we have found that up to 50% of cells from EBs differentiated for 4 days express Flk-1. Following the development of this early Flk-1+ population the number of receptor-positive cells declines progressively to represent less than 5% of the EBs by day 12 of differentiation. Kinetic analysis revealed that the establishment of the EB Flk-1+ population precedes the development of cells which express CD34, Ly6A (Sca-1) and AA4.1. Cell sorting experiments demonstrated that all day-4 EB-derived hematopoietic precursors are Flk-1+ whereas greater than 95% of those found within the day-12 EBs are Flk-1-, suggesting that the precursor population which expresses this receptor represents an early but transient wave of hematopoietic development. Analysis of yolk sac and whole embryos at day 8.5 of gestation revealed a small but distinct Flk-1+ population that contained hematopoietic precursors. Day-12.5 fetal liver contained few Flk-1+ cells that showed little hematopoietic potential. Together these findings indicate that Flk-1 is expressed on an early population of hematopoietic precursors that may represent the onset of embryonic hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169850     DOI: 10.1242/dev.124.10.2039

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  79 in total

1.  Origins of circulating endothelial cells and endothelial outgrowth from blood.

Authors:  Y Lin; D J Weisdorf; A Solovey; R P Hebbel
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

2.  SCL/tal-1-dependent process determines a competence to select the definitive hematopoietic lineage prior to endothelial differentiation.

Authors:  Mitsuhiro Endoh; Minetaro Ogawa; Stuart Orkin; Shin-ichi Nishikawa
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

3.  Pluripotent differentiation in vitro of murine ES-D3 embryonic stem cells.

Authors:  Arazdordi Toumadje; Ken-Ichi Kusumoto; Angela Parton; Patricia Mericko; Lori Dowell; Guozhong Ma; Luping Chen; David W Barnes; J Denry Sato
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Nov-Dec       Impact factor: 2.416

4.  Unique differentiation profile of mouse embryonic stem cells in rotary and stirred tank bioreactors.

Authors:  Krista M Fridley; Irina Fernandez; Mon-Tzu Alice Li; Robert B Kettlewell; Krishnendu Roy
Journal:  Tissue Eng Part A       Date:  2010-07-12       Impact factor: 3.845

Review 5.  Establishment and regulation of the HSC niche: Roles of osteoblastic and vascular compartments.

Authors:  Suleyman Coskun; Karen K Hirschi
Journal:  Birth Defects Res C Embryo Today       Date:  2010-12

6.  SCL/Tal-1 is essential for hematopoietic commitment of the hemangioblast but not for its development.

Authors:  Sunita L D'Souza; Andrew G Elefanty; Gordon Keller
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

7.  Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures.

Authors:  Marion Kennedy; Sunita L D'Souza; Macarena Lynch-Kattman; Staci Schwantz; Gordon Keller
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

8.  Both primitive and definitive blood cells are derived from Flk-1+ mesoderm.

Authors:  Jesse J Lugus; Changwon Park; Yunglin D Ma; Kyunghee Choi
Journal:  Blood       Date:  2008-10-28       Impact factor: 22.113

9.  Tunica interna endothelial cell kinase expression and hematopoietic and angiogenic potentials in cord blood CD34+ cells.

Authors:  Mika Wada; Yasuhiro Ebihara; Feng Ma; Hiroshi Yagasaki; Mamoru Ito; Tsuneo Takahashi; Hideo Mugishima; Shigeru Takahashi; Kohichiro Tsuji
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

10.  A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development.

Authors:  Brandon K Hadland; Stacey S Huppert; Jyotshnabala Kanungo; Yingzi Xue; Rulang Jiang; Thomas Gridley; Ronald A Conlon; Alec M Cheng; Raphael Kopan; Gregory D Longmore
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.